A Phase I Clinical Study of GLR2037 in Patients With Advanced Prostate Cancer

NCT07468396 · clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
65
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Gan & Lee Pharmaceuticals.